CASI PHARMACEUTICALS, INC. Operating Lease, Expense
CASI PHARMACEUTICALS, INC. reported Operating Lease, Expense of $1.30 million for the 12-month period ending 2022-12-31, per its 20-F filed 2023-04-26.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseExpense · last filed 2023-04-26
- CASI PHARMACEUTICALS, INC. operating lease, expense for the quarter ending 2022-12-31 was $300.00K, a 0.00% change year-over-year.
- CASI PHARMACEUTICALS, INC. operating lease, expense for the quarter ending 2022-09-30 was $300.00K, a 25.00% decline year-over-year.
- CASI PHARMACEUTICALS, INC. operating lease, expense for the quarter ending 2022-06-30 was $300.00K, a 25.00% decline year-over-year.
- CASI PHARMACEUTICALS, INC. operating lease, expense for the quarter ending 2022-03-31 was $400.00K, a 0.00% change year-over-year.
- CASI PHARMACEUTICALS, INC. operating lease, expense for fiscal 2019 was $1.31M, a 43.56% increase from fiscal 2018.
- CASI PHARMACEUTICALS, INC. operating lease, expense for fiscal 2018 was $916.00K.
| Period end | Operating Lease, Expense 3 month | Operating Lease, Expense 6 month | Operating Lease, Expense 6 month as first filed | Operating Lease, Expense 9 month | Operating Lease, Expense 9 month as first filed | Operating Lease, Expense 12 month | Operating Lease, Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2022-12-31 | $300.00K derived: 20-F 12 month − 10-Q 9 month · filed 2023-04-26 | $600.00K derived: sum of 2 quarters · filed 2023-04-26 | $900.00K derived: sum of 3 quarters · filed 2023-04-26 | $1.30M 20-F · filed 2023-04-26 | |||
| 2022-09-30 | $300.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $600.00K derived: sum of 2 quarters · filed 2022-11-14 | $1.00M 10-Q · filed 2022-11-14 | $1.30M derived: sum of 4 quarters · filed 2023-04-26 | |||
| 2022-06-30 | $300.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $700.00K 10-Q · filed 2022-08-12 | $1.00M derived: sum of 3 quarters · filed 2023-04-26 | $1.40M derived: sum of 4 quarters · filed 2023-04-26 | |||
| 2022-03-31 | $400.00K 10-Q · filed 2022-05-12 | $700.00K derived: sum of 2 quarters · filed 2023-04-26 | $1.10M derived: sum of 3 quarters · filed 2023-04-26 | $1.50M derived: sum of 4 quarters · filed 2023-04-26 | |||
| 2021-12-31 | $300.00K derived: 20-F 12 month − 10-Q 9 month · filed 2023-04-26 | $700.00K derived: sum of 2 quarters · filed 2023-04-26 | $1.10M derived: sum of 3 quarters · filed 2023-04-26 | $1.50M 20-F · filed 2023-04-26 | $1.45M 10-K · filed 2022-03-28 | ||
| 2021-09-30 | $400.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $800.00K derived: sum of 2 quarters · filed 2022-11-14 | $1.20M 10-Q · filed 2022-11-14 | $1.16M 10-Q · filed 2021-11-12 | $1.65M derived: sum of 4 quarters · filed 2023-04-26 | ||
| 2021-06-30 | $400.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $800.00K 10-Q · filed 2022-08-12 | $789.00K 10-Q · filed 2021-08-12 | $1.25M derived: sum of 3 quarters · filed 2023-04-26 | $1.65M derived: sum of 4 quarters · filed 2023-04-26 | ||
| 2021-03-31 | $400.00K 10-Q · filed 2022-05-12 | $847.00K derived: sum of 2 quarters · filed 2023-04-26 | $1.25M derived: sum of 3 quarters · filed 2023-04-26 | $1.62M derived: sum of 4 quarters · filed 2023-04-26 | |||
| 2020-12-31 | $447.00K derived: 20-F 12 month − 10-Q 9 month · filed 2023-04-26 | $851.00K derived: sum of 2 quarters · filed 2023-04-26 | $1.22M derived: sum of 3 quarters · filed 2023-04-26 | $1.60M 20-F · filed 2023-04-26 | |||
| 2020-09-30 | $404.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $776.00K derived: sum of 2 quarters · filed 2021-11-12 | $1.15M 10-Q · filed 2021-11-12 | $1.51M derived: sum of 4 quarters · filed 2021-11-12 | |||
| 2020-06-30 | $372.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $749.00K 10-Q · filed 2021-08-12 | $1.11M derived: sum of 3 quarters · filed 2021-08-12 | $1.45M derived: sum of 4 quarters · filed 2021-08-12 | |||
| 2020-03-31 | $377.00K 10-Q · filed 2021-05-13 | $735.00K derived: sum of 2 quarters · filed 2021-05-13 | $1.08M derived: sum of 3 quarters · filed 2021-05-13 | $1.39M derived: sum of 4 quarters · filed 2021-05-13 | |||
| 2019-12-31 | $358.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | $704.00K derived: sum of 2 quarters · filed 2021-03-30 | $1.01M derived: sum of 3 quarters · filed 2021-03-30 | $1.31M 10-K · filed 2021-03-30 | |||
| 2019-09-30 | $346.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $656.00K derived: sum of 2 quarters · filed 2020-11-09 | $957.00K 10-Q · filed 2020-11-09 | ||||
| 2019-06-30 | $310.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $611.00K 10-Q · filed 2020-08-10 | |||||
| 2019-03-31 | $301.00K 10-Q · filed 2020-05-11 | ||||||
| 2018-12-31 | $916.00K 10-K · filed 2020-03-16 |